Literature DB >> 20142585

Cardiotoxicity after childhood cancer: beginning with the end in mind.

Steven E Lipshultz, M Jacob Adams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142585     DOI: 10.1200/JCO.2009.26.5751

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  52 in total

1.  Why multidisciplinary clinics should be the standard for treating chronic kidney disease.

Authors:  Guido Filler; Steven E Lipshultz
Journal:  Pediatr Nephrol       Date:  2012-07-04       Impact factor: 3.714

2.  Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.

Authors:  David C Landy; Tracie L Miller; Gabriela Lopez-Mitnik; Stuart R Lipsitz; Andrea S Hinkle; Louis S Constine; Carol A French; Amy M K Rovitelli; M Jacob Adams; Steven E Lipshultz
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

3.  Left ventricular mass and ambulatory blood pressure are increased in long-term survivors of childhood cancer after autologous SCT.

Authors:  A Vatanen; T H Ojala; T Sarkola; M Turanlahti; T Jahnukainen; U M Saarinen-Pihkala; K Jahnukainen
Journal:  Bone Marrow Transplant       Date:  2016-02-01       Impact factor: 5.483

4.  The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.

Authors:  Zuyue Sun; Jill Schriewer; Mingxin Tang; Jerry Marlin; Frederick Taylor; Ralph V Shohet; Eugene A Konorev
Journal:  J Mol Cell Cardiol       Date:  2015-12-11       Impact factor: 5.000

5.  How to Improve the Safe and Effective Use of Doxorubicin in Children with Cancer.

Authors:  John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2015-11       Impact factor: 6.447

6.  Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.

Authors:  Joseph R Carver; Dava Szalda; Bonnie Ky
Journal:  Semin Oncol       Date:  2013-04       Impact factor: 4.929

7.  A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.

Authors:  Rui Zhang; Rebecca M Howell; Phillip J Taddei; Annelise Giebeler; Anita Mahajan; Wayne D Newhauser
Journal:  Radiother Oncol       Date:  2014-08-12       Impact factor: 6.280

8.  Imaging doxorubicin and polymer-drug conjugates of doxorubicin-induced cardiotoxicity with bispecific anti-myosin-anti-DTPA antibody and Tc-99m-labeled polymers.

Authors:  Rajiv Panwar; Prashant Bhattarai; Vishwesh Patil; Keyur Gada; Stan Majewski; Ban An Khaw
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

9.  Assessment of myocardial fibrosis using T1-mapping and extracellular volume measurement on cardiac magnetic resonance imaging for the diagnosis of radiation-induced cardiomyopathy.

Authors:  Natsuko Mukai-Yatagai; Nobuhiko Haruki; Yoshiharu Kinugasa; Yasutoshi Ohta; Hatsue Ishibashi-Ueda; Toshihiko Akasaka; Masahiko Kato; Toshihide Ogawa; Kazuhiro Yamamoto
Journal:  J Cardiol Cases       Date:  2018-06-30

Review 10.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.